CEO, Sustained Theraeputics
William Annett is a senior executive whose career has focused on leadership, operational and finance roles in rapidly growing life sciences companies. CEO of five early-stage companies, he took two public (on both NASDAQ and the NYSE) and exited a third via acquisition. As Partner at Accenture he led the U.S. West Coast Life Sciences practice. During eight years at Genentech he led the Product Launch Office, directed the Project Finance function managing the $1 billion Development budget, and ran a successful $150 million operational transformation project. He served on the Board of Directors of the California Life Sciences Association for six years. Mr. Annett received his MBA from the Harvard Business School.